FindTrial
Sign In

Prospective Registry Study of Lung cancer in Jiangsu Province, China

Prospective Registry Study of Lung cancer in Jiangsu Province, China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099342
Enrollment
Unknown
Registered
2025-03-21
Start date
2022-04-29
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Observation group:NONE

Sponsors

General Hospital Of Eastern Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. No age, no gender; 2. Understand the research procedure and content, and voluntarily sign a written informed consent; 3. lung cancer confirmed by histopathology or cytology;

Exclusion criteria

Exclusion criteria: 1. Patients who refuse to participate in enrolled studies.

Design outcomes

Primary

MeasureTime frame
Overall survival time;—

Secondary

MeasureTime frame
Progression free survival time;Objective response rate;Disease control rate;Duration of remission;safty;—

Countries

China

Contacts

Public ContactYong Song

General Hospital Of Eastern Theater Command

yong.song@nju.edu.cn+86 25 8086 0114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026